ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0012

Dichotomous Expression of CXCR3 and CCR9 and Relationship to Intestinal Permeability in B Cells in Rheumatoid Arthritis

Ken Yasaka, Ruoqiao Wang, Nida Pellett, Daria Krenitsky, Juilee Thakar and Jennifer Anolik, University of Rochester Medical Center, Rochester, NY

Meeting: ACR Convergence 2024

Keywords: B-Lymphocyte, chemokines, microbiome, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The gut is a key mucosal tissue that can impact the immune system and contribute to systemic inflammation in the setting of increased intestinal permeability. The levels of serum zonulin, a surrogate marker of intestinal permeability, have been reported to be increased in patients with rheumatoid arthritis (RA) and pre-onset RA. In a model mice of RA increased zonulin was associated with immune cell migration from the gut to the synovium. We postulated that gut permeability may be a driver of pathogenic B cells involved in the pathogenesis of human RA.

Methods: Zonulin levels were measured by ELISA in sera from 17 healthy donors (HD) and 21 patients with RA. Paired PBMCs were analyzed by flow cytometry. Naïve B cells (IgD+ and CD27-) were classified into resting (rNAV, CD11c- and CD21+) and activated (acNAV, CD11c+ and CD21-). Among IgD- antigen-experienced B cells, autoimmunity/age-associated B cells (ABC) were defined as CD27-, CD11c+ and CD21-. Antibody-secreting cells (ASC) were defined as CD27++ and CD38++. Chemokine receptor expression was examined as a read-out of cell migration potential, CCR9 for gut-homing and CXCR3 for migration to inflammatory tissues. We also looked at the expression of those chemokine receptors in single cell analysis data from the Accelerating Medicines Partnership Program: Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Network.

Results: Our RA cohort was characterized by long-standing seropositive disease (70% duration > 5 years; 82 % positive for anti-CCP antibodies). RA had significantly higher levels of serum zonulin than HD, and this was inversely correlated with CCR9+ and CCR9+ IgA+ ASC. ABC and acNAV were significantly more abundant in RA than HD (ABC, 0.9% vs 0.35%, p < 0.05; acNAV, 0.78% vs 0.56%, p < 0.05), but their frequencies were not correlated with zonulin.
CXCR3 and CCR9 were exclusively expressed on IgD- subsets (CXCR3% on IgD- 15% vs rNAV 0.78%, CCR9% 7.0% vs 0.69%). Notably, CXCR3 and CCR9 expression was mutually exclusive, and their frequencies were inversely correlated in RA (p = 0.066, Spearman’s correlation test). Compared to CCR9+ B cells, both T-bet+ and IgG+ B cells were significantly enriched in CXCR3+ B cells, while IgA+ B cells were more enriched in CCR9+ B cells. Despite the low frequencies (0.73%), CCR9+ CXCR3+ B cells primarily comprise IgA+ CD11c+ T-bet+ B cells. When synovial B cells from AMP RA/SLE Network were analyzed, CCR9 expression was notably absent in most of the B cell subsets, but CXCR3 expression was enriched in ABCs.  0.05

Conclusion: Our study implicates increased gut permeability and ABC expansion in long-standing RA. Dichotomous phenotypes of CXCR3+ and CCR9+ in antigen-experienced B cells may reflect different developmental pathways and migration propensity. Given there is little evidence on the role of IgA+ B cells in RA, the ongoing studies are underway to assess the functional difference between IgG+ and IgA+ B cells in the synovium. We will also examine clonal relationships between B cell populations in the blood and synovium to capture the dynamics of their migration.

Supporting image 1

The boxplot comparing serum zonulin levels between HD and RA. The Mann-Whitney U test was done.

Supporting image 2

The scatter plots showing the correlation between zonulin and the frequencies of CCR9+ ASC (A) and CCR9+ IgA+ (B) in RA.
Spearman’s correlation test was done.

Supporting image 3

A. A representative scatter plot of IgD- B cells from RA showing exclusive expression of CXCR3 and CCR9.
B. The boxplot figures showing the frequencies of each subset delineated in IgD- B cells in RA and HD.
C. The boxplot figures showing the positivity of T-bet, IgG and IgA in CXCR3+ and CCR9+ IgD- B cells. The Mann-Whitney U test was done.


Disclosures: K. Yasaka: None; R. Wang: None; N. Pellett: None; D. Krenitsky: None; J. Thakar: None; J. Anolik: None.

To cite this abstract in AMA style:

Yasaka K, Wang R, Pellett N, Krenitsky D, Thakar J, Anolik J. Dichotomous Expression of CXCR3 and CCR9 and Relationship to Intestinal Permeability in B Cells in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/dichotomous-expression-of-cxcr3-and-ccr9-and-relationship-to-intestinal-permeability-in-b-cells-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dichotomous-expression-of-cxcr3-and-ccr9-and-relationship-to-intestinal-permeability-in-b-cells-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology